Clinical Trial Update: Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT

View source ↗

Summary

This entry notes a terminated observational study at Stanford evaluating the RCHOP chemotherapy regimen with or without radiation therapy for diffuse large B-ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Lymphoma
• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Stanford University | Conditions: Lymphoma, Non-Hodgkin's Lymphoma | Status: TERMINATED